… -to-moderate Covid-19, treatment options … at high risk for progression to severe Covid-19.
Although monoclonal antibodies significantly reduce the risk of progression to severe Covid-19…

… Although epidemiological and clinical characteristics of Covid-19 have been constantly …
in Covid-19, or how Covid-19 affects obesity and diabetes, or special treatment in these at-risk …

… days before presenting with COVID-19 were found to have a higher risk of severe events …
highest risk for severe complications and was correlated with poorer outcomes from COVID-19…

… of respiratory illness caused by Coronavirus disease 2019 (COVID-19) emerged in Wuhan,
… to identify high-risk groups whose mental health conditions were vulnerable to the COVID-19 …

… To evaluate whether TE increases the risk of mortality among patients with COVID-19, we
estimated pooled Mantel–Haenszel odds ratios (OR) for mortality using a random effects model…

… access to care in the setting of COVID-19 while facilitating physical distancing.[5] … COVID-19
pandemic, the purpose of this manuscript is to review the adoption of telehealth for high-risk …

… A next priority is to directly protect those who are at highest risk … But if a vaccine offers little
to no protection in high-risk … protection to high-risk groups, leaving the most vulnerable at risk. …

… Covid-19 Convalescent Plasma in Outpatients (C3PO) trial involving patients at high risk for
severe Covid-19 … high titers of neutralizing antibodies would prevent progression to severe …

… In conclusion, in a retrospective cohort study evaluating high-risk COVID-19 patients,
regdanvimab treatment within seven days of symptom onset was associated with decreased risk of …

… commonly referred to as the Coronavirus, is disrupting societies and … COVID-19 is a
tremendous challenge for occupational health. Workers in many occupations are facing high risks of …